Law RH, Caradoc-Davies T, Cowieson N, Horvath AJ, Quek AJ, Encarnacao JA, Steer D, Cowan A, Zhang Q, Lu BG, Pike RN, Smith AI, Coughlin PB, Whisstock JC (March 2012). "The X-ray crystal structure of full-length human plasminogen". Cell Reports1 (3): 185–90. PMID22832192. doi:10.1016/j.celrep.2012.02.012.
Gurman P, Miranda OR, Nathan A, Washington C, Rosen Y, Elman NM (March 2015). "Recombinant tissue plasminogen activators (rtPA): a review". Clinical Pharmacology and Therapeutics97 (3): 274–85. PMID25670034. doi:10.1002/cpt.33.
Declerck PJ, Gils A (June 2013). "Three decades of research on plasminogen activator inhibitor-1: a multifaceted serpin". Seminars in Thrombosis and Hemostasis39 (4): 356–64. PMID23504606. doi:10.1055/s-0033-1334487.
Mikus P, Urano T, Liljeström P, Ny T (December 1993). "Plasminogen-activator inhibitor type 2 (PAI-2) is a spontaneously polymerising SERPIN. Biochemical characterisation of the recombinant intracellular and extracellular forms". European Journal of Biochemistry218 (3): 1071–82. PMID7506655. doi:10.1111/j.1432-1033.1993.tb18467.x.
Rivera-Bou WL (15 December 2016). "Thrombolytic Therapy". MedScape. Consultado o 28 February 2017.
nih.gov
ncbi.nlm.nih.gov
Law RH, Caradoc-Davies T, Cowieson N, Horvath AJ, Quek AJ, Encarnacao JA, Steer D, Cowan A, Zhang Q, Lu BG, Pike RN, Smith AI, Coughlin PB, Whisstock JC (March 2012). "The X-ray crystal structure of full-length human plasminogen". Cell Reports1 (3): 185–90. PMID22832192. doi:10.1016/j.celrep.2012.02.012.
Gurman P, Miranda OR, Nathan A, Washington C, Rosen Y, Elman NM (March 2015). "Recombinant tissue plasminogen activators (rtPA): a review". Clinical Pharmacology and Therapeutics97 (3): 274–85. PMID25670034. doi:10.1002/cpt.33.
Declerck PJ, Gils A (June 2013). "Three decades of research on plasminogen activator inhibitor-1: a multifaceted serpin". Seminars in Thrombosis and Hemostasis39 (4): 356–64. PMID23504606. doi:10.1055/s-0033-1334487.
Mimuro J (May 1991). "[Type 1 plasminogen activator inhibitor: its role in biological reactions]". [Rinsho Ketsueki] the Japanese Journal of Clinical Hematology32 (5): 487–9. PMID1870265.
Mikus P, Urano T, Liljeström P, Ny T (December 1993). "Plasminogen-activator inhibitor type 2 (PAI-2) is a spontaneously polymerising SERPIN. Biochemical characterisation of the recombinant intracellular and extracellular forms". European Journal of Biochemistry218 (3): 1071–82. PMID7506655. doi:10.1111/j.1432-1033.1993.tb18467.x.